Abdominal Vagus Nerve Stimulation Increases Firing in the Rat Locus Coeruleus.

IF 3.2 3区 医学 Q2 CLINICAL NEUROLOGY
Tomoko Hyakumura, Sophie C Payne, Jerico V Matarazzo, Wendy K Adams, James B Fallon
{"title":"Abdominal Vagus Nerve Stimulation Increases Firing in the Rat Locus Coeruleus.","authors":"Tomoko Hyakumura, Sophie C Payne, Jerico V Matarazzo, Wendy K Adams, James B Fallon","doi":"10.1016/j.neurom.2025.05.003","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Cervical vagus nerve stimulation (VNS) is a clinically available treatment for refractory epilepsy and depression. Animal studies show that electrical activation of the noradrenergic brain region, locus coeruleus (LC), is essential for the therapeutic effects of cervical VNS for the treatment of these conditions. Cervical VNS often causes side effects such as coughing, headache, and apnea-hypopnea. Such side effects can be mitigated by reducing stimulation intensity; however, evidence suggests this reduces efficacy of treatment. Abdominal VNS, targeting the vagus nerve below the nerve branches that cause these side effects, is an alternative strategy to deliver VNS.</p><p><strong>Objective: </strong>This study aimed to assess whether abdominal VNS increases spike activity in the LC without causing any off-target effects.</p><p><strong>Materials and methods: </strong>Cervical and abdominal vagi of anesthetized male Sprague-Dawley rats were implanted with cuff electrode arrays, and a tungsten electrode was used to record neural activity in the LC. Changes in the firing rate of LC neurons and changes to the heart and breathing rate were recorded during cervical and abdominal VNS.</p><p><strong>Results: </strong>Cervical VNS significantly reduced heart and/or breathing rate (two-way repeated measures analysis of variance, p < 0.05; n = 6) when stimulation was 0.82 ± 0.09 mA or higher. This stimulation level was termed the \"off-target effect threshold.\" Abdominal VNS did not produce any changes in heart and breathing rate at any stimulus level tested. Cervical and abdominal VNS, delivered at 2 mA (maximum tested) significantly increased spike activity predominantly in the anteromedial LC, compared with prestimulation baseline (paired t-test, p < 0.001, n = 6). However, when \"safe levels,\" that is, below the off-target effect threshold, of VNS were applied, only abdominal VNS increased spike activity in the LC.</p><p><strong>Conclusion: </strong>Abdominal VNS activated the LC without causing changes to vitals and could be used as an alternative approach to providing VNS therapy for brain disorders such as drug-resistant epilepsy and depression.</p>","PeriodicalId":19152,"journal":{"name":"Neuromodulation","volume":" ","pages":""},"PeriodicalIF":3.2000,"publicationDate":"2025-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuromodulation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.neurom.2025.05.003","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Cervical vagus nerve stimulation (VNS) is a clinically available treatment for refractory epilepsy and depression. Animal studies show that electrical activation of the noradrenergic brain region, locus coeruleus (LC), is essential for the therapeutic effects of cervical VNS for the treatment of these conditions. Cervical VNS often causes side effects such as coughing, headache, and apnea-hypopnea. Such side effects can be mitigated by reducing stimulation intensity; however, evidence suggests this reduces efficacy of treatment. Abdominal VNS, targeting the vagus nerve below the nerve branches that cause these side effects, is an alternative strategy to deliver VNS.

Objective: This study aimed to assess whether abdominal VNS increases spike activity in the LC without causing any off-target effects.

Materials and methods: Cervical and abdominal vagi of anesthetized male Sprague-Dawley rats were implanted with cuff electrode arrays, and a tungsten electrode was used to record neural activity in the LC. Changes in the firing rate of LC neurons and changes to the heart and breathing rate were recorded during cervical and abdominal VNS.

Results: Cervical VNS significantly reduced heart and/or breathing rate (two-way repeated measures analysis of variance, p < 0.05; n = 6) when stimulation was 0.82 ± 0.09 mA or higher. This stimulation level was termed the "off-target effect threshold." Abdominal VNS did not produce any changes in heart and breathing rate at any stimulus level tested. Cervical and abdominal VNS, delivered at 2 mA (maximum tested) significantly increased spike activity predominantly in the anteromedial LC, compared with prestimulation baseline (paired t-test, p < 0.001, n = 6). However, when "safe levels," that is, below the off-target effect threshold, of VNS were applied, only abdominal VNS increased spike activity in the LC.

Conclusion: Abdominal VNS activated the LC without causing changes to vitals and could be used as an alternative approach to providing VNS therapy for brain disorders such as drug-resistant epilepsy and depression.

腹部迷走神经刺激增加大鼠蓝斑区的放电。
背景:颈迷走神经刺激(VNS)是临床上治疗难治性癫痫和抑郁症的有效方法。动物研究表明,脑蓝斑(LC)的去肾上腺素能区域的电激活对于颈椎VNS治疗这些疾病的治疗效果至关重要。颈椎VNS常引起咳嗽、头痛、呼吸暂停低通气等副作用。这些副作用可以通过降低刺激强度来减轻;然而,有证据表明,这降低了治疗效果。腹部迷走神经刺激是另一种治疗迷走神经的方法,其目标是引起这些副作用的神经分支下方的迷走神经。目的:本研究旨在评估腹部VNS是否在不引起任何脱靶效应的情况下增加LC的尖峰活性。材料与方法:在麻醉后的雄性sd - dawley大鼠颈、腹迷走神经内植入袖带电极阵列,用钨电极记录LC神经活动。记录颈、腹迷走神经刺激时LC神经元放电频率的变化、心跳和呼吸频率的变化。结果:颈椎VNS显著降低心脏和/或呼吸频率(双向重复测量方差分析,p < 0.05;刺激≥0.82±0.09 mA时n = 6)。这种刺激水平被称为“脱靶效应阈值”。在测试的任何刺激水平下,腹部VNS均未引起心脏和呼吸速率的任何变化。与刺激前基线相比,以2 mA(最大测试值)给药的颈部和腹部VNS显著增加了前内侧LC的尖峰活性(配对t检验,p < 0.001, n = 6)。然而,当使用VNS的“安全水平”,即低于脱靶效应阈值时,只有腹部VNS增加了LC的spike活性。结论:腹腔VNS激活LC而不引起生命体征改变,可作为一种替代方法,为耐药癫痫、抑郁症等脑部疾病提供VNS治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Neuromodulation
Neuromodulation 医学-临床神经学
CiteScore
6.40
自引率
3.60%
发文量
978
审稿时长
54 days
期刊介绍: Neuromodulation: Technology at the Neural Interface is the preeminent journal in the area of neuromodulation, providing our readership with the state of the art clinical, translational, and basic science research in the field. For clinicians, engineers, scientists and members of the biotechnology industry alike, Neuromodulation provides timely and rigorously peer-reviewed articles on the technology, science, and clinical application of devices that interface with the nervous system to treat disease and improve function.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信